• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

使用多标签反应类别推荐器增强基于反应的从头设计。

Enhancing reaction-based de novo design using a multi-label reaction class recommender.

机构信息

Information School, University of Sheffield, Regent Court, 211 Portobello, Sheffield, S1 4DP, UK.

Evotec (U.K.) Ltd, 114 Innovation Drive, Milton Park, Abingdon, OX14 4RZ, UK.

出版信息

J Comput Aided Mol Des. 2020 Jul;34(7):783-803. doi: 10.1007/s10822-020-00300-6. Epub 2020 Feb 28.

DOI:10.1007/s10822-020-00300-6
PMID:32112286
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7293200/
Abstract

Reaction-based de novo design refers to the in-silico generation of novel chemical structures by combining reagents using structural transformations derived from known reactions. The driver for using reaction-based transformations is to increase the likelihood of the designed molecules being synthetically accessible. We have previously described a reaction-based de novo design method based on reaction vectors which are transformation rules that are encoded automatically from reaction databases. A limitation of reaction vectors is that they account for structural changes that occur at the core of a reaction only, and they do not consider the presence of competing functionalities that can compromise the reaction outcome. Here, we present the development of a Reaction Class Recommender to enhance the reaction vector framework. The recommender is intended to be used as a filter on the reaction vectors that are applied during de novo design to reduce the combinatorial explosion of in-silico molecules produced while limiting the generated structures to those which are most likely to be synthesisable. The recommender has been validated using an external data set extracted from the recent medicinal chemistry literature and in two simulated de novo design experiments. Results suggest that the use of the recommender drastically reduces the number of solutions explored by the algorithm while preserving the chance of finding relevant solutions and increasing the global synthetic accessibility of the designed molecules.

摘要

基于反应的从头设计是指通过使用结构转换来组合试剂,从而在计算机上生成新的化学结构,这些结构转换源自已知反应。使用基于反应的转换的驱动因素是增加所设计分子具有合成可及性的可能性。我们之前描述了一种基于反应向量的基于反应的从头设计方法,反应向量是从反应数据库自动编码的转换规则。反应向量的一个限制是,它们仅考虑反应核心发生的结构变化,而不考虑可能影响反应结果的竞争功能基团的存在。在这里,我们提出了一种反应类推荐器的开发,以增强反应向量框架。该推荐器旨在用作在从头设计中应用的反应向量的过滤器,以减少在计算机上生成的分子的组合爆炸,同时将生成的结构限制在最有可能可合成的结构。该推荐器已使用从最近的药物化学文献中提取的外部数据集和两个模拟从头设计实验进行了验证。结果表明,使用推荐器可以大大减少算法探索的解决方案数量,同时保留找到相关解决方案的机会,并增加所设计分子的全球合成可及性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f6e3/7293200/110299539f92/10822_2020_300_Fig18_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f6e3/7293200/7063e61ddd15/10822_2020_300_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f6e3/7293200/6347a658f3d0/10822_2020_300_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f6e3/7293200/99fad3ff42cf/10822_2020_300_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f6e3/7293200/f620b7551a01/10822_2020_300_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f6e3/7293200/96d3fdf4213d/10822_2020_300_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f6e3/7293200/5f28bc0a0b50/10822_2020_300_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f6e3/7293200/dee852fa2727/10822_2020_300_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f6e3/7293200/58f2d5f203bd/10822_2020_300_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f6e3/7293200/c4fa98ff00f0/10822_2020_300_Fig9_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f6e3/7293200/4e98f1cab7ee/10822_2020_300_Fig10_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f6e3/7293200/8f01bc4f347e/10822_2020_300_Fig11_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f6e3/7293200/1868bfa4bb88/10822_2020_300_Fig12_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f6e3/7293200/8d83012b4272/10822_2020_300_Fig13_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f6e3/7293200/9364b648a8d9/10822_2020_300_Fig14_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f6e3/7293200/d5dd2e267c32/10822_2020_300_Fig15_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f6e3/7293200/007c123e910d/10822_2020_300_Fig16_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f6e3/7293200/48face9a649f/10822_2020_300_Fig17_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f6e3/7293200/110299539f92/10822_2020_300_Fig18_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f6e3/7293200/7063e61ddd15/10822_2020_300_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f6e3/7293200/6347a658f3d0/10822_2020_300_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f6e3/7293200/99fad3ff42cf/10822_2020_300_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f6e3/7293200/f620b7551a01/10822_2020_300_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f6e3/7293200/96d3fdf4213d/10822_2020_300_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f6e3/7293200/5f28bc0a0b50/10822_2020_300_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f6e3/7293200/dee852fa2727/10822_2020_300_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f6e3/7293200/58f2d5f203bd/10822_2020_300_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f6e3/7293200/c4fa98ff00f0/10822_2020_300_Fig9_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f6e3/7293200/4e98f1cab7ee/10822_2020_300_Fig10_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f6e3/7293200/8f01bc4f347e/10822_2020_300_Fig11_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f6e3/7293200/1868bfa4bb88/10822_2020_300_Fig12_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f6e3/7293200/8d83012b4272/10822_2020_300_Fig13_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f6e3/7293200/9364b648a8d9/10822_2020_300_Fig14_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f6e3/7293200/d5dd2e267c32/10822_2020_300_Fig15_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f6e3/7293200/007c123e910d/10822_2020_300_Fig16_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f6e3/7293200/48face9a649f/10822_2020_300_Fig17_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f6e3/7293200/110299539f92/10822_2020_300_Fig18_HTML.jpg

相似文献

1
Enhancing reaction-based de novo design using a multi-label reaction class recommender.使用多标签反应类别推荐器增强基于反应的从头设计。
J Comput Aided Mol Des. 2020 Jul;34(7):783-803. doi: 10.1007/s10822-020-00300-6. Epub 2020 Feb 28.
2
Synthetically accessible de novo design using reaction vectors: Application to PARP1 inhibitors.使用反应向量的合成可及的从头设计:在PARP1抑制剂中的应用。
Mol Inform. 2024 Apr;43(4):e202300183. doi: 10.1002/minf.202300183. Epub 2024 Feb 6.
3
Multistep Reaction Based De Novo Drug Design: Generating Synthetically Feasible Design Ideas.基于多步反应的从头药物设计:生成合成可行的设计思路。
J Chem Inf Model. 2016 Apr 25;56(4):605-20. doi: 10.1021/acs.jcim.5b00697. Epub 2016 Apr 14.
4
RENATE: A Pseudo-retrosynthetic Tool for Synthetically Accessible de novo Design.雷纳特:一种用于具有合成可达性的从头设计的伪逆合成工具。
Mol Inform. 2022 Apr;41(4):e2100207. doi: 10.1002/minf.202100207. Epub 2021 Nov 8.
5
Creating the New from the Old: Combinatorial Libraries Generation with Machine-Learning-Based Compound Structure Optimization.推陈出新:基于机器学习的化合物结构优化生成组合文库
J Chem Inf Model. 2017 Feb 27;57(2):133-147. doi: 10.1021/acs.jcim.6b00426. Epub 2017 Feb 15.
6
Multi-objective Genetic Algorithm for De Novo Drug Design (MoGADdrug).多目标遗传算法的从头药物设计(MoGADdrug)。
Curr Comput Aided Drug Des. 2021;17(3):445-457. doi: 10.2174/1573409916666200620194143.
7
Recent Advances in Automated Structure-Based De Novo Drug Design.基于结构的从头药物设计的最新进展。
J Chem Inf Model. 2024 Mar 25;64(6):1794-1805. doi: 10.1021/acs.jcim.4c00247. Epub 2024 Mar 14.
8
Second-generation de novo design: a view from a medicinal chemist perspective.第二代从头设计:药物化学家的视角。
J Comput Aided Mol Des. 2009 Aug;23(8):593-602. doi: 10.1007/s10822-009-9291-2. Epub 2009 Jun 27.
9
Computer-aided design of small molecules for chemical genomics.用于化学基因组学的小分子计算机辅助设计
Methods Mol Biol. 2005;310:25-39. doi: 10.1007/978-1-59259-948-6_3.
10
Is chemical synthetic accessibility computationally predictable for drug and lead-like molecules? A comparative assessment between medicinal and computational chemists.化学合成可及性对于药物和类先导分子是否可计算预测?药物化学家和计算化学家之间的比较评估。
Eur J Med Chem. 2012 Aug;54:679-89. doi: 10.1016/j.ejmech.2012.06.024. Epub 2012 Jun 21.

引用本文的文献

1
Synthetically accessible de novo design using reaction vectors: Application to PARP1 inhibitors.使用反应向量的合成可及的从头设计:在PARP1抑制剂中的应用。
Mol Inform. 2024 Apr;43(4):e202300183. doi: 10.1002/minf.202300183. Epub 2024 Feb 6.
2
Navigating chemical reaction space - application to DNA-encoded chemistry.探索化学反应空间——在DNA编码化学中的应用
Chem Sci. 2022 Sep 1;13(37):11221-11231. doi: 10.1039/d2sc02474h. eCollection 2022 Sep 28.
3
Drugsniffer: An Open Source Workflow for Virtually Screening Billions of Molecules for Binding Affinity to Protein Targets.

本文引用的文献

1
Development and Application of a Data-Driven Reaction Classification Model: Comparison of an Electronic Lab Notebook and Medicinal Chemistry Literature.基于数据驱动的反应分类模型的开发与应用:电子实验记录本与药物化学文献的比较。
J Chem Inf Model. 2019 Oct 28;59(10):4167-4187. doi: 10.1021/acs.jcim.9b00537. Epub 2019 Sep 26.
2
A poised fragment library enables rapid synthetic expansion yielding the first reported inhibitors of PHIP(2), an atypical bromodomain.一个平衡的片段文库能够实现快速的合成扩展,从而产生首个被报道的针对非典型溴结构域PHIP(2)的抑制剂。
Chem Sci. 2016 Mar 1;7(3):2322-2330. doi: 10.1039/c5sc03115j. Epub 2015 Dec 22.
3
药物嗅探器:一种用于虚拟筛选数十亿种与蛋白质靶点具有结合亲和力的分子的开源工作流程。
Front Pharmacol. 2022 Apr 26;13:874746. doi: 10.3389/fphar.2022.874746. eCollection 2022.
4
Towards the De Novo Design of HIV-1 Protease Inhibitors Based on Natural Products.基于天然产物的 HIV-1 蛋白酶抑制剂的从头设计。
Biomolecules. 2021 Dec 1;11(12):1805. doi: 10.3390/biom11121805.
5
RENATE: A Pseudo-retrosynthetic Tool for Synthetically Accessible de novo Design.雷纳特:一种用于具有合成可达性的从头设计的伪逆合成工具。
Mol Inform. 2022 Apr;41(4):e2100207. doi: 10.1002/minf.202100207. Epub 2021 Nov 8.
Automatic Chemical Design Using a Data-Driven Continuous Representation of Molecules.
使用数据驱动的分子连续表示法进行自动化学设计。
ACS Cent Sci. 2018 Feb 28;4(2):268-276. doi: 10.1021/acscentsci.7b00572. Epub 2018 Jan 12.
4
Generating Focused Molecule Libraries for Drug Discovery with Recurrent Neural Networks.使用递归神经网络生成用于药物发现的聚焦分子库。
ACS Cent Sci. 2018 Jan 24;4(1):120-131. doi: 10.1021/acscentsci.7b00512. Epub 2017 Dec 28.
5
The rise of deep learning in drug discovery.深度学习在药物发现中的崛起。
Drug Discov Today. 2018 Jun;23(6):1241-1250. doi: 10.1016/j.drudis.2018.01.039. Epub 2018 Jan 31.
6
Application of Generative Autoencoder in De Novo Molecular Design.生成式自动编码器在从头分子设计中的应用。
Mol Inform. 2018 Jan;37(1-2). doi: 10.1002/minf.201700123. Epub 2017 Dec 13.
7
ExCAPE-DB: an integrated large scale dataset facilitating Big Data analysis in chemogenomics.ExCAPE-DB:一个促进化学基因组学大数据分析的综合大规模数据集。
J Cheminform. 2017 Mar 7;9:17. doi: 10.1186/s13321-017-0203-5. eCollection 2017.
8
Chemical Space Mimicry for Drug Discovery.用于药物发现的化学空间模拟
J Chem Inf Model. 2017 Apr 24;57(4):875-882. doi: 10.1021/acs.jcim.6b00754. Epub 2017 Apr 3.
9
Classification Models for Predicting Cytochrome P450 Enzyme-Substrate Selectivity.预测细胞色素P450酶底物选择性的分类模型
Mol Inform. 2012 Jan;31(1):53-62. doi: 10.1002/minf.201100052. Epub 2012 Jan 2.
10
De Novo Design at the Edge of Chaos.处于混沌边缘的从头设计。
J Med Chem. 2016 May 12;59(9):4077-86. doi: 10.1021/acs.jmedchem.5b01849. Epub 2016 Feb 16.